[ Price : $8.95]
FDA approves an Allecra Therapeutics NDA for Exblifep (cefepime/enmetazobactam) for treating complicated urinary tract infections.[ Price : $8.95]
FDA updates a Class 1 recall (correction) of Megadyne Medical Products Mega Soft patient return electrode models to reiterate the ...[ Price : $8.95]
FDA posts a draft guidance on Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigat...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Clinical Pharmacology Considerations for Antibody-Drug Conj...[ Price : $8.95]
Federal Register: FDA announces a publication containing modifications the agency is making to the list of standards it recognizes...[ Price : $8.95]
FDA grants full approval to Johnson & Johnsons Rybrevant (amivantamab-vmjw) in combination with chemotherapy for the first-line tr...[ Price : $8.95]
CDRHs Binita Ashar says a recent journal article on breast implant risk provided useful information for patients and providers abo...[ Price : $8.95]
FDA publishes a guidance to assist in the development of antibody-drug conjugates with a cytotoxic small-molecule drug or payload.